Markers, Conjugates, Compositions and Methods for Hypoxia Imaging, Mapping, and Therapy
Summary
USPTO granted patent US12600742B2 to WWIKY Biosciences Inc. on April 14, 2026. The patent covers markers, conjugates, compositions and methods for hypoxia imaging, mapping, and therapy using bio-reductively activated compounds with click chemistry. Inventors include Piyush Kumar, Hassan Elsaidi, Leonard Irving Wiebe, and Michael Weinfeld. The patent includes 5 claims.
What changed
USPTO issued patent grant US12600742B2 to WWIKY Biosciences Inc. for hypoxia imaging technology. The patent covers bio-reductively activated compounds with nitroimidazoles, benzotriazene dioxides, triazoles, and benzoquinones, combined with linker arms and click chemistry for medical imaging applications including PET/SPECT and fluorescent reporting.
For biotech and pharmaceutical companies developing hypoxia-targeted imaging agents or therapeutics, this patent establishes intellectual property boundaries that may require licensing or design-around strategies. Researchers in this space should conduct freedom-to-operate analyses before commercializing related products.
What to do next
- Monitor patent portfolio for infringement
- Review licensing opportunities
Archived snapshot
Apr 14, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Markers, conjugates, compositions and methods for hypoxia imaging, mapping, and therapy
Grant US12600742B2 Kind: B2 Apr 14, 2026
Assignee
WWIKY Biosciences Inc.
Inventors
Piyush Kumar, Hassan Elsaidi, Leonard Irving Wiebe, Michael Weinfeld
Abstract
Described herein are markers, conjugates, compositions and methods for hypoxia imaging, mapping, and therapy. A compound comprising bio-reductively activated (BA) arm, linker arm and a mapping click wherein BA contains one for more of substituted or unsubstituted 2/4/5-substituted nitroimidazoles, or substituted benzotriazene-1,4-dioxides, or substituted 1,2,3/1,2,4-triazoles, or substituted 1,4-benzoquinones, or a combination of two homo-or hetero BA moieties, wherein linker arm contains C1-16 alkane, alkene, alkyne, alicyclic or aromatic linkers with or without hetero atoms as in ethers, amine, esters, acid, amides, 5 and 6 membered sugar sings with the substitution as described above, both monosaccharides and disaccharides, wherein mapping click contains one of substituted or unsubstituted —N3-, CN, SCN, substituted alkynes for click chemistry. Said compound undergoes in situ click reaction after its distribution in cells or tissues to link to a reporting group which may be unchelated or chelated with a metal-radioactive or non-radioactive-, or a radiohalogen for PET/SPECT, or a dye for fluorescent/optical reporting group, thus accomplishing hypoxia imaging.
CPC Classifications
C07H 15/26 C07D 245/08 C07D 403/12 C07D 405/14 C07D 405/04 A61K 51/0453 A61K 51/0461 A61K 51/0497
Filing Date
2018-09-19
Application No.
16648338
Claims
5
Related changes
Get daily alerts for USPTO Patent Grants - Organic Chemistry (C07D)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Organic Chemistry (C07D) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.